Your session is about to expire
← Back to Search
Contact Lens
LID226397, then AOfAHP for Astigmatism
N/A
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 dispense, 10 minutes after lens insertion, for each wear period. each wear period is approximately 14 days.
Awards & highlights
Study Summary
This trial tests how well a type of contact lens fits and works for people who need correction for astigmatism.
Eligible Conditions
- Astigmatism
- Farsightedness
- Refractive Errors
- Near-sightedness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 dispense, 10 minutes after lens insertion, for each wear period. each wear period is approximately 14 days.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 dispense, 10 minutes after lens insertion, for each wear period. each wear period is approximately 14 days.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of lenses with axis orientation within ± 30 degrees from the intended axis at 10 minutes after lens insertion
Trial Design
2Treatment groups
Experimental Treatment
Group I: LID226397, then AOfAHPExperimental Treatment3 Interventions
Serafilcon A toric contact lenses worn in Period 1, with senofilcon A toric contact lenses worn in Period 2. Each product will be worn bilaterally (in both eyes) during waking hours for approximately 14 days. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.
Group II: AOfAHP, then LID226397Experimental Treatment3 Interventions
Senofilcon A toric contact lenses worn in Period 1, with serafilcon A toric contact lenses worn in Period 2. Each product will be worn bilaterally (in both eyes) during waking hours for approximately 14 days. CLEAR CARE will be used for nightly contact lens cleaning and disinfection.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Serafilcon A toric contact lenses
2023
N/A
~100
Senofilcon A toric contact lenses
2023
N/A
~100
CLEAR CARE
2022
N/A
~1570
Find a Location
Who is running the clinical trial?
Alcon ResearchLead Sponsor
704 Previous Clinical Trials
124,419 Total Patients Enrolled
44 Trials studying Astigmatism
8,352 Patients Enrolled for Astigmatism
Clinical Trial Lead, CRD Vision CareStudy DirectorAlcon Research, LLC
6 Previous Clinical Trials
1,708 Total Patients Enrolled
1 Trials studying Astigmatism
76 Patients Enrolled for Astigmatism
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been regularly wearing contact lenses overnight (sleeping with them) at least once a week for the past 3 months.There may be additional reasons why you cannot participate in the study.Your visual acuity must be at least 20/25 Snellen (0.10 logMAR) in each eye, as determined by refraction examination upon enrollment.You have successfully worn any commercial soft toric contact lenses (except AOfAHP and daily disposable lenses) in both eyes for at least 3 months with a minimum wearing time of 5 days per week and 10 hours per day.You are able to wear contact lenses that align with the available range of spherical and cylindrical power, as well as its axes.You may need to meet additional criteria determined by the protocol.
Research Study Groups:
This trial has the following groups:- Group 1: LID226397, then AOfAHP
- Group 2: AOfAHP, then LID226397
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any locations in North America that are administering this research?
"The trial is being conducted in numerous sites, such as Pacific Rims Optometry in San Francisco, Florida; Drs. Giedd, P.A. located in Maitland, Illinois; and Vision Health Institute based in Orlando, Ohio - with 7 other locations spread across the United States of America."
Answered by AI
Are there still openings available for participation in this research project?
"As per the information on clinicaltrials.gov, this trial is not presently enrolling any candidates; it was initially posted 8/1/2023 and last edited 7/24/2023. Nevertheless, there are currently 171 other trials that require participants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger